SMSPHARMA — SMS Pharmaceuticals Balance Sheet
0.000.00%
- IN₹22.51bn
- IN₹25.10bn
- IN₹7.83bn
- 72
- 18
- 64
- 52
Annual balance sheet for SMS Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 404 | 466 | 73.8 | 360 | 513 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,262 | 716 | 1,715 | 2,502 | 2,036 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3,093 | 3,771 | 4,106 | 5,339 | 5,545 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4,625 | 4,476 | 4,437 | 4,649 | 5,655 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 8,122 | 8,595 | 8,796 | 10,341 | 11,527 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,941 | 1,965 | 2,549 | 3,317 | 3,244 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 4,017 | 3,892 | 4,191 | 4,978 | 5,130 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 4,105 | 4,703 | 4,605 | 5,363 | 6,396 |
Total Liabilities & Shareholders' Equity | 8,122 | 8,595 | 8,796 | 10,341 | 11,527 |
Total Common Shares Outstanding |